Tertiary Nav - Press Releases Press ReleasesMedia Statements Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 12/13/10 AVI BioPharma Names Chris Garabedian Chief Executive Officer 11/15/10 AVI BioPharma to Present at Maxim Group Growth Conference 2010 11/11/10 AVI BioPharma to Present Data for RNA-Based Influenza Drug Candidates at 2010 Chemical and Biological Defense Science and Technology Conference 11/9/10 AVI BioPharma Announces Third Quarter 2010 Financial Results 11/3/10 AVI BioPharma Awarded $1.2 Million in U.S. Government Grants for Five Qualifying Therapeutic Development Projects Involving RNA-Based Drug Candidates 11/2/10 AVI BioPharma Announces Third Quarter 2010 Financial Results and Corporate Update Conference Call 10/27/10 AVI BioPharma Announces Key Leadership Appointments to Advance Capabilities in Drug Discovery, Research and Development 10/20/10 Data From AVI BioPharma's RNA-Based Influenza and Dengue Virus Programs to Be Presented at 48th Annual Meeting of Infectious Diseases Society of America 10/20/10 AVI BioPharma to Present Data on RNA-Based Duchenne Muscular Dystrophy and Influenza Drug Candidates at 6th Annual Meeting of the Oligonucleotide Therapeutics Society 10/19/10 AVI BioPharma to Present at the BioCentury NewsMakers in the Biotech Industry Conference Pagination First page « first Previous page ‹ previous … Page 57 Page 58 Page 59 Page 60 Current page 61 Page 62 Page 63 Page 64 Page 65 … Next page next › Last page last » Displaying 601 - 610 of 813 Toolkit Print Page | Email Alerts | RSS Feeds | Contacts
Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 12/13/10 AVI BioPharma Names Chris Garabedian Chief Executive Officer 11/15/10 AVI BioPharma to Present at Maxim Group Growth Conference 2010 11/11/10 AVI BioPharma to Present Data for RNA-Based Influenza Drug Candidates at 2010 Chemical and Biological Defense Science and Technology Conference 11/9/10 AVI BioPharma Announces Third Quarter 2010 Financial Results 11/3/10 AVI BioPharma Awarded $1.2 Million in U.S. Government Grants for Five Qualifying Therapeutic Development Projects Involving RNA-Based Drug Candidates 11/2/10 AVI BioPharma Announces Third Quarter 2010 Financial Results and Corporate Update Conference Call 10/27/10 AVI BioPharma Announces Key Leadership Appointments to Advance Capabilities in Drug Discovery, Research and Development 10/20/10 Data From AVI BioPharma's RNA-Based Influenza and Dengue Virus Programs to Be Presented at 48th Annual Meeting of Infectious Diseases Society of America 10/20/10 AVI BioPharma to Present Data on RNA-Based Duchenne Muscular Dystrophy and Influenza Drug Candidates at 6th Annual Meeting of the Oligonucleotide Therapeutics Society 10/19/10 AVI BioPharma to Present at the BioCentury NewsMakers in the Biotech Industry Conference Pagination First page « first Previous page ‹ previous … Page 57 Page 58 Page 59 Page 60 Current page 61 Page 62 Page 63 Page 64 Page 65 … Next page next › Last page last » Displaying 601 - 610 of 813